Literature DB >> 12938529

Preliminary clinical application of contrast-enhanced MR portography.

L Yang1, X Kong, D Liu, X Xiao, G Feng.   

Abstract

The clinical application of contrast enhanced (CE) MR was evaluated. A total of 66 CE MR portograms were obtained by performing fast imaging with steady procession (FISP) technique on a 1.5-T Siemens magnetom vision. A maximum intensity projection algorithm was also employed to include all vessels in a single image. The patency of portal venous system, the presence and extent of varices were also evaluated. The results showed that all images had diagnostic quality. Main portal vein (MPV) and its 4th-6th level intrahepatic branches were visualized in 10 normal persons serving as control. The diameter of MPV, splenic vein and superior mesenteric vein was 1.02 +/- 0.21, 0.8 +/- 0.15, 0.8 +/- 0.26 cm respectively, which were significantly lower than that in portal hypertension patients (1.38 +/- 0.27, 1.26 +/- 0.18, 1.24 +/- 0.18 cm, respectively). In 23 preoperative cases of portal hypertension, dilated portal vein and tortuous enlarged splenic vein were found in 23 cases; esophageal and coronary varices in 12 and 19 cases, respectively. In 7 postoperative re-examined cases with portal hypertension, the flow velocity and flow of MPV were decreased in all cases and esophageal varices could still be observed in 3 cases. New vessels appeared in the great curvature of stomach in 2 cases. In 20 cases of liver carcinoma, occlusion of MPV or its intrahepatic branches were showed in 14, compression and dislocation of intrahepatic portal vein were found in 6. In other 6 cases, 2 were splenic venous thrombosis and 4 were tumors in the intestine or retro-peritoneum. It is concluded that three-dimensional CE MR portography is an accurate technique for evaluating the portal venous system. It is a reliable and noninvasive technique that can provide important information for the evaluation of patients' condition before TIPSS and liver transplantation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 12938529     DOI: 10.1007/bf02886974

Source DB:  PubMed          Journal:  J Tongji Med Univ        ISSN: 0257-716X


  7 in total

1.  Breath-hold, contrast-enhanced, three-dimensional MR angiography.

Authors:  D A Leung; G C McKinnon; C P Davis; T Pfammatter; G P Krestin; J F Debatin
Journal:  Radiology       Date:  1996-08       Impact factor: 11.105

2.  Mesenteric circulation: three-dimensional MR angiography with a gadolinium-enhanced multiecho gradient-echo technique.

Authors:  A Shirkhoda; O Konez; A N Shetty; K G Bis; R A Ellwood; M J Kirsch
Journal:  Radiology       Date:  1997-01       Impact factor: 11.105

3.  Portal vein patency in candidates for liver transplantation: MR angiographic analysis.

Authors:  J M Silverman; L Podesta; F Villamil; L Sher; J Vierling; S Rojter; A Hoffman; R Lopez; P Rosenthal; G Woolf
Journal:  Radiology       Date:  1995-10       Impact factor: 11.105

4.  Liver transplantation: dynamic contrast-enhanced magnetic resonance imaging of the hepatic vasculature.

Authors:  J Ward; J A Spencer; J A Guthrie; P J Robinson
Journal:  Clin Radiol       Date:  1996-03       Impact factor: 2.350

5.  Dynamic contrast-enhanced MR imaging of the portal venous system: comparison with x-ray angiography.

Authors:  P M Rodgers; J Ward; C J Baudouin; J P Ridgway; P J Robinson
Journal:  Radiology       Date:  1994-06       Impact factor: 11.105

6.  Imaging of the portal venous system in patients with cirrhosis: MR angiography vs duplex Doppler sonography.

Authors:  J P Finn; R A Kane; R R Edelman; R L Jenkins; W D Lewis; M Muller; H E Longmaid
Journal:  AJR Am J Roentgenol       Date:  1993-11       Impact factor: 3.959

7.  Preoperative staging of cancer of the pancreas: value of MR angiography versus conventional angiography in detecting portal venous invasion.

Authors:  E G McFarland; J A Kaufman; S Saini; E F Halpern; D S Lu; A C Waltman; A L Warshaw
Journal:  AJR Am J Roentgenol       Date:  1996-01       Impact factor: 3.959

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.